Clinical Trials Logo

Clinical Trial Summary

The study is a multicenter, open-label Phase 1b single dose escalation safety study for adult subjects with intractable pain associated with cancer in any area below the mid-thoracic level who meet all other eligibility criteria.


Clinical Trial Description

All subjects who received RTX will be included in the analyses and summaries of safety, efficacy, PD, and PK assessments. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03226574
Study type Interventional
Source Sorrento Therapeutics, Inc.
Contact
Status Completed
Phase Phase 1
Start date September 1, 2017
Completion date June 18, 2020